For over three decades, CEI has advocated health care reforms that put more power in the hands of consumers to choose their health providers, treatment protocols, and scope of insurance coverage. We have advocated reform of the Food and Drug Administration’s drug and device approval process to allow for greater flexibility and patient choice. And in 2013, CEI organized the court challenges to Obamacare’s exchange subsidies that concluded with the Supreme Court’s King v. Burwell decision.
Healthcare Issue Areas
Featured Posts
Blog
State Directed Payments redistribute money across states and supercharged growth
Differences in states’ use of SDPs cause an interstate redistribution of taxes as well. Because states are setting different levels of SDPs, spending varies…
Blog
How State Directed Payments turned Medicaid into an interstate transfer scheme
Medicaid’s financing rules have long allowed states to expand spending while shifting much of the cost to federal taxpayers. One of the most important…
Blog
Medicaid financing gimmickry – before and after the One Big Beautiful Bill
Medicaid was created in 1965 as a joint federal-state health insurance program for low-income individuals which targeted families with dependent children, the elderly, and…
Search Posts
Op-Eds
Creating Cow Concerns Should Make Mad Consumers
<?xml:namespace prefix = st1 ns = “urn:schemas-microsoft-com:office:smarttags” />U.S. consumers are known for their affection for food, so it's a wonder most Americans…
Op-Eds
No, Not the NHS!
Whenever I hear the words “universal health care” — as I did during Sunday night's Democratic debate in <?xml:namespace prefix = st1 ns =…
Op-Eds
Technology for Life: How Biotech Will Save Billions from Starvation
Full article available in pdf format Today, most people around the world have access to a greater variety of nutritious…
Op-Eds
“Direct Action” The Tactics of Radical Activism: Part 1, How Environmental Groups Use Violent Tactics to Advance their
Full article available as a pdf. <?xml:namespace prefix = st1 ns = “urn:schemas-microsoft-com:office:smarttags” />July 8, 2000 –Kwajalein Atoll,…
Op-Eds
GMO Patent Nonsense
One of the most contentious issues in the debate over GM crops and foods is the existence of intellectual property protection and patents…
Op-Eds
Europe’s Dangerous Over-Precaution
European Union (EU) officials are deliberating on whether to apply the “precautionary principle” to nearly all chemicals in commerce within the EU—a move that could…
